Literature DB >> 10593950

Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein.

M R Ladomery1, J Slight, S Mc Ghee, N D Hastie.   

Abstract

The tumor suppressor gene WT1 encodes a zinc finger protein, which consists of four C-terminal C(2)-H(2) zinc fingers of the Krüppel type, and at the N terminus a Q/P-rich trans-regulatory domain, both characteristic of transcription factors. However, recent findings suggest that WT1 may also be involved in a post-transcriptional process. Specifically, WT1 isoforms containing the alternatively spliced exon 9 (+lysine-threonine-serine (KTS)) preferentially associate with nuclear speckles and co-immunoprecipitate splicing antigens (Larsson, S. H., Charlieu, J.-P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., van Heyningen, V., and Hastie, N. D. (1995) Cell 81, 391-401); furthermore, WT1 has been shown to interact with the ubiquitous splicing factor U2AF65 (Davies, R. C., Calvo, C., Larsson, S. H., Lamond, A. I., and Hastie, N. D. (1998) Genes Dev. 12, 3217-3225) and binds to RNA in vitro (Caricasole, A., Duarte, A., Larsson, S. H., Hastie, N. D., Little, M., Holmes, G., Todorov, I., and Ward, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 7562-7566; Bardeesy, N., and Pelletier, J. (1998) Nucleic Acids Res. 26, 1784-1792). To extend these findings, we have fractionated nuclear extracts to see if particles containing WT1 have the properties of ribonucleoprotein (RNP). In summary, WT1 is enriched by oligo(dT) chromatography, as are U2AF65, the U5 small nuclear RNP-associated protein p116 and hnRNP A1. Gel filtration and sedimentation profiles suggest that WT1 is present in RNase-sensitive particles, >2 MDa in size, peaking at approximately 60 S, and approximately 1.27 g/cm(3) on Nycodenz. Similar results were obtained from two cell lines expressing WT1, fetal kidneys (day E17), and transiently transfected cells, suggesting that the presence of WT1 protein in nuclear poly(A)(+) RNP is a general aspect of WT1 function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10593950     DOI: 10.1074/jbc.274.51.36520

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  A proteomic analysis of oligo(dT)-bound mRNP containing oxidative stress-induced Arabidopsis thaliana RNA-binding proteins ATGRP7 and ATGRP8.

Authors:  Fabian Schmidt; Aline Marnef; Man-Kim Cheung; Ian Wilson; John Hancock; Dorothee Staiger; Michael Ladomery
Journal:  Mol Biol Rep       Date:  2009-08-12       Impact factor: 2.316

2.  Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1.

Authors:  D J Richard; V Schumacher; B Royer-Pokora; S G Roberts
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

3.  The Wilms' tumor 1 (WT1) gene (+KTS isoform) functions with a CTE to enhance translation from an unspliced RNA with a retained intron.

Authors:  Yeou-cherng Bor; Jennifer Swartz; Avril Morrison; David Rekosh; Michael Ladomery; Marie-Louise Hammarskjöld
Journal:  Genes Dev       Date:  2006-05-31       Impact factor: 11.361

4.  The Wilms' tumor gene Wt1 is required for normal development of the retina.

Authors:  Kay-Dietrich Wagner; Nicole Wagner; Valerie P I Vidal; Gunnar Schley; Dagmar Wilhelm; Andreas Schedl; Christoph Englert; Holger Scholz
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.

Authors:  Maike Busch; Heinrich Schwindt; Artur Brandt; Manfred Beier; Nicole Görldt; Paul Romaniuk; Eneda Toska; Stefan Roberts; Hans-Dieter Royer; Brigitte Royer-Pokora
Journal:  Hum Mol Genet       Date:  2014-03-11       Impact factor: 6.150

6.  Polymorphisms in the Wilms Tumor Gene Are Associated With Interindividual Variations in Rubella Virus-Specific Cellular Immunity After Measles-Mumps-Rubella II Vaccination.

Authors:  Emily A Voigt; Iana H Haralambieva; Beth L Larrabee; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  J Infect Dis       Date:  2018-01-30       Impact factor: 5.226

7.  Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1.

Authors:  Nicole Wagner; Kay-Dietrich Wagner; Heinz Theres; Christoph Englert; Andreas Schedl; Holger Scholz
Journal:  Genes Dev       Date:  2005-11-01       Impact factor: 11.361

8.  Mice lacking the 68-amino-acid, mammal-specific N-terminal extension of WT1 develop normally and are fertile.

Authors:  Colin G Miles; Joan Slight; Lee Spraggon; Maureen O'Sullivan; Charles Patek; Nicholas D Hastie
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 9.  Regulation of gene expression by WT1 in development and tumorigenesis.

Authors:  Leif W Ellisen
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

10.  BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1.

Authors:  Brian Carpenter; Kathryn J Hill; Marika Charalambous; Kate J Wagner; Diya Lahiri; Dominic I James; Jens S Andersen; Valérie Schumacher; Brigitte Royer-Pokora; Matthias Mann; Andrew Ward; Stefan G E Roberts
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.